Home/Filings/4/0000899243-21-002048

4//SEC Filing

Jovan-Embiricos Morana 4

Accession 0000899243-21-002048

CIK 0001789972other

View on SEC.gov Company Profile

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 5:30 PM ET

Size

61.8 KB

Accession

0000899243-21-002048

Insider Transaction Report

Form 4

Period: 2021-01-12

Cullinan Management, Inc.CGEM

F2 MG Ltd

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)

Holdings

Common Stock
112,507

F2 MC, LLC

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)

Holdings

Common Stock
112,507

F2 GC, LLC

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)

Holdings

Common Stock
112,507

Jovan-Embiricos Morana

Director10% Owner

Transactions

Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)

Holdings

Common Stock
112,507

F2 Vision SCS

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)

Holdings

Common Stock
112,507

F2 Bioscience I 2017 Ltd

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)

Holdings

Common Stock
112,507

F2 - TPO Investments LLC

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)

Holdings

Common Stock
112,507

F2 Bio TD, LLC

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)

Holdings

Common Stock
112,507

Globeways Holdings Ltd

10% Owner

Transactions

Conversion
Common Stock
2021-01-12+2,912,345→ 2,912,345 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+1,136,525→ 1,136,525 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+455,338→ 455,338 total(indirect: See Footnote)
Conversion
Series Seed Convertible Preferred Stock
2021-01-12−8,000,000→ 0 total(indirect: See Footnote)
→ Common Stock (1,136,525 underlying)
Conversion
Series B Convertible Preferred Stock
2021-01-12−3,205,128→ 0 total(indirect: See Footnote)
→ Common Stock (455,338 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Conversion
Common Stock
2021-01-12+639,295→ 639,295 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 526,937 total(indirect: See Footnote)
Conversion
Series A Convertible Preferred Stock
2021-01-12−20,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (2,912,345 underlying)
Conversion
Series A Convertible Preferred Stock
2021-01-12−4,500,000→ 0 total(indirect: See Footnote)
→ Common Stock (639,295 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,511,966→ 0 total(indirect: See Footnote)
→ Common Stock (214,798 underlying)
Conversion
Common Stock
2021-01-12+182,135→ 182,135 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+143,198→ 325,333 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+71,599→ 71,599 total(indirect: See Footnote)
Conversion
Common Stock
2021-01-12+214,798→ 214,798 total(indirect: See Footnote)
Purchase
Common Stock
2021-01-12$21.00/sh+95,238$1,999,998→ 622,175 total(indirect: See Footnote)
Conversion
Series C Convertible Preferred Stock
2021-01-12−1,007,977→ 0 total(indirect: See Footnote)
→ Common Stock (143,198 underlying)
Conversion
Series C Convertible Preferred Stock
2021-01-12−503,988→ 0 total(indirect: See Footnote)
→ Common Stock (71,599 underlying)
Purchase
Common Stock
2021-01-12$21.00/sh+104,762$2,200,002→ 104,762 total(indirect: See Footnote)
Conversion
Series B Convertible Preferred Stock
2021-01-12−1,282,051→ 0 total(indirect: See Footnote)
→ Common Stock (182,135 underlying)

Holdings

Common Stock
112,507

Footnotes (9)

[F1]Each share of Series Seed Preferred Stock, Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock (the "Preferred Stock') converted into Common Stock of the Issuer on a 1-for-7.0390 basis at the closing of the Issuer's initial public offering on January 12, 2021. The Preferred Stock had no expiration date.
[F2]These securities are owned directly by Globeways Holdings Limited ("Globeways"). The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by Globeways. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F3]These securities are owned directly by F2 Vision SCS ("F2 Vision"). F2 Vision Management Sarl ("F2 Vision Management") is the appointed manager of F2 Vision. The Reporting Person is the founding director of F2 Vision Management and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Vision. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F4]These securities are owned directly by F2 Bioscience I 2017 Limited ("F2 Bioscience 2017"). Globeways is the appointed manager of F2 Bioscience 2017. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bioscience 2017. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F5]These securities are owned directly by F2-TPO Investments, LLC ("F2-TPO"). Globeways Holdings II Limited ("Globeways II") is the appointed manager of F2-TPO. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2-TPO. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F6]These securities are owned directly by F2 MG Limited ("F2 MG"). Globeways is the appointed manager of F2 MG. The Reporting Person is the founding director of Globeways and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MG. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F7]These securities are owned directly by F2 Bio TD, LLC ("F2 Bio"). Globeways II is the appointed manager of F2 Bio. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 Bio. . The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F8]These securities are owned directly by F2 MC, LLC ("F2 MC"). Globeways II is the appointed manager of F2 MC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 MC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
[F9]These securities are owned directly by F2 GC LLC ("F2 GC"). Globeways II is the appointed manager of F2 GC. The Reporting Person is the founding director of Globeways II and has the sole power to vote upon the acquisition, holding and disposal of all shares held by F2 GC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Cullinan Management, Inc.

CIK 0001789972

→

Entity typeother

Related Parties

filerCIK 0001575745

Filing Metadata

Form type: 4
Filed: Jan 13, 7:00 PM ET
Accepted: Jan 14, 5:30 PM ET
Size: 61.8 KB

View on SEC.gov